NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 315 filers reported holding NEOGENOMICS INC in Q2 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $444,387 | -35.1% | 36,129 | -15.2% | 0.00% | -50.0% |
| Q2 2023 | $684,667 | +85057.6% | 42,606 | -7.7% | 0.00% | 0.0% |
| Q1 2023 | $804 | +57.6% | 46,177 | -16.4% | 0.00% | 0.0% |
| Q4 2022 | $510 | -99.9% | 55,238 | +0.1% | 0.00% | 0.0% |
| Q3 2022 | $475,000 | +13.6% | 55,210 | +7.4% | 0.00% | 0.0% |
| Q2 2022 | $418,000 | -31.5% | 51,394 | +2.3% | 0.00% | 0.0% |
| Q1 2022 | $610,000 | -62.1% | 50,239 | +6.5% | 0.00% | -71.4% |
| Q4 2021 | $1,609,000 | -36.0% | 47,156 | -9.6% | 0.01% | -46.2% |
| Q3 2021 | $2,516,000 | +7.5% | 52,165 | +0.7% | 0.01% | -13.3% |
| Q2 2021 | $2,340,000 | -8.8% | 51,814 | -2.6% | 0.02% | -16.7% |
| Q1 2021 | $2,565,000 | – | 53,192 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,785,605 | $86,138,000 | 34.19% |
| PERKINS CAPITAL MANAGEMENT INC | 157,750 | $7,610,000 | 4.71% |
| Blue Water Life Science Advisors, LP | 222,222 | $10,719,000 | 3.49% |
| First Light Asset Management, LLC | 1,055,960 | $50,940,000 | 3.36% |
| Ranger Investment Management | 810,956 | $39,121,000 | 2.09% |
| Bullseye Asset Management LLC | 108,054 | $5,212,000 | 1.81% |
| Lombard Odier Asset Management (Switzerland) SA | 584,281 | $28,186,000 | 1.75% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 998,858 | $48,185,000 | 1.67% |
| EMERALD ADVISERS, LLC | 904,298 | $43,623,000 | 1.58% |
| Soleus Capital Management, L.P. | 190,556 | $9,192,000 | 1.43% |